#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4 .
1-1	0-1	4	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Discussion
2-1	4-14	Discussion	abstract	new	_	_

#Text=Renewed focus on functional and quality of life outcomes after surgery for DCM in adults has come from rigorous scrutiny of the results of several large-scale studies in the last decade .
3-1	15-22	Renewed	abstract[3]	new[3]	coref	5-30[33_3]
3-2	23-28	focus	abstract[3]	new[3]	_	_
3-3	29-31	on	abstract[3]	new[3]	_	_
3-4	32-42	functional	abstract[3]	new[3]	_	_
3-5	43-46	and	abstract[3]	new[3]	_	_
3-6	47-54	quality	abstract[3]|abstract	new[3]|new	coref	4-35
3-7	55-57	of	_	_	_	_
3-8	58-62	life	abstract|abstract[6]	new|new[6]	coref|coref|coref|coref	3-22[11_6]|4-37|3-22[11_6]|4-37
3-9	63-71	outcomes	abstract[6]	new[6]	_	_
3-10	72-77	after	_	_	_	_
3-11	78-85	surgery	event[7]	new[7]	coref	4-8[0_7]
3-12	86-89	for	event[7]	new[7]	_	_
3-13	90-93	DCM	event[7]|abstract[8]	new[7]|new[8]	coref	6-15[0_8]
3-14	94-96	in	event[7]|abstract[8]	new[7]|new[8]	_	_
3-15	97-103	adults	event[7]|abstract[8]|person	new[7]|new[8]|new	coref	12-23[89_0]
3-16	104-107	has	_	_	_	_
3-17	108-112	come	_	_	_	_
3-18	113-117	from	_	_	_	_
3-19	118-126	rigorous	abstract[10]	new[10]	_	_
3-20	127-135	scrutiny	abstract[10]	new[10]	_	_
3-21	136-138	of	abstract[10]	new[10]	_	_
3-22	139-142	the	abstract[10]|abstract[11]	new[10]|giv[11]	coref	6-10[37_11]
3-23	143-150	results	abstract[10]|abstract[11]	new[10]|giv[11]	_	_
3-24	151-153	of	abstract[10]|abstract[11]	new[10]|giv[11]	_	_
3-25	154-161	several	abstract[10]|abstract[11]|abstract[12]	new[10]|giv[11]|new[12]	coref	5-33[34_12]
3-26	162-173	large-scale	abstract[10]|abstract[11]|abstract[12]	new[10]|giv[11]|new[12]	_	_
3-27	174-181	studies	abstract[10]|abstract[11]|abstract[12]	new[10]|giv[11]|new[12]	_	_
3-28	182-184	in	abstract[10]|abstract[11]|abstract[12]	new[10]|giv[11]|new[12]	_	_
3-29	185-188	the	abstract[10]|abstract[11]|abstract[12]|time[13]	new[10]|giv[11]|new[12]|new[13]	_	_
3-30	189-193	last	abstract[10]|abstract[11]|abstract[12]|time[13]	new[10]|giv[11]|new[12]|new[13]	_	_
3-31	194-200	decade	abstract[10]|abstract[11]|abstract[12]|time[13]	new[10]|giv[11]|new[12]|new[13]	_	_
3-32	201-202	.	_	_	_	_

#Text=The traditional doctrine of the use of surgery to ‘ arrest clinical progression ’ has been replaced with a more modern approach with decompressive surgery used as a means to provide both functional and quality of life improvement .
4-1	203-206	The	abstract[14]	new[14]	_	_
4-2	207-218	traditional	abstract[14]	new[14]	_	_
4-3	219-227	doctrine	abstract[14]	new[14]	_	_
4-4	228-230	of	abstract[14]	new[14]	_	_
4-5	231-234	the	abstract[14]|abstract[15]	new[14]|new[15]	_	_
4-6	235-238	use	abstract[14]|abstract[15]	new[14]|new[15]	_	_
4-7	239-241	of	abstract[14]|abstract[15]	new[14]|new[15]	_	_
4-8	242-249	surgery	abstract[14]|abstract[15]|event	new[14]|new[15]|giv	coref	4-24[20_0]
4-9	250-252	to	abstract[14]|abstract[15]	new[14]|new[15]	_	_
4-10	253-254	‘	abstract[14]|abstract[15]	new[14]|new[15]	_	_
4-11	255-261	arrest	abstract[14]|abstract[15]|event	new[14]|new[15]|new	_	_
4-12	262-270	clinical	abstract[14]|abstract[15]|abstract[18]	new[14]|new[15]|new[18]	_	_
4-13	271-282	progression	abstract[14]|abstract[15]|abstract[18]	new[14]|new[15]|new[18]	_	_
4-14	283-284	’	abstract[14]|abstract[15]|abstract[18]	new[14]|new[15]|new[18]	_	_
4-15	285-288	has	_	_	_	_
4-16	289-293	been	_	_	_	_
4-17	294-302	replaced	_	_	_	_
4-18	303-307	with	_	_	_	_
4-19	308-309	a	abstract[19]	new[19]	_	_
4-20	310-314	more	abstract[19]	new[19]	_	_
4-21	315-321	modern	abstract[19]	new[19]	_	_
4-22	322-330	approach	abstract[19]	new[19]	_	_
4-23	331-335	with	abstract[19]	new[19]	_	_
4-24	336-349	decompressive	abstract[19]|event[20]	new[19]|giv[20]	coref	6-13[38_20]
4-25	350-357	surgery	abstract[19]|event[20]	new[19]|giv[20]	_	_
4-26	358-362	used	_	_	_	_
4-27	363-365	as	_	_	_	_
4-28	366-367	a	_	_	_	_
4-29	368-373	means	_	_	_	_
4-30	374-376	to	_	_	_	_
4-31	377-384	provide	_	_	_	_
4-32	385-389	both	_	_	_	_
4-33	390-400	functional	_	_	_	_
4-34	401-404	and	_	_	_	_
4-35	405-412	quality	abstract	giv	coref	5-4[25_0]
4-36	413-415	of	_	_	_	_
4-37	416-420	life	abstract|abstract[23]	giv|new[23]	coref|coref|coref|coref	5-6|20-17[140_23]|5-6|20-17[140_23]
4-38	421-432	improvement	abstract[23]	new[23]	_	_
4-39	433-434	.	_	_	_	_

#Text=The assessment of quality of life metrics has become particularly important in the examination of patients with mild functional impairment ( or asymptomatic cord compression ) , and is the focus of a number of studies .
5-1	435-438	The	abstract[24]	new[24]	coref	22-26[157_24]
5-2	439-449	assessment	abstract[24]	new[24]	_	_
5-3	450-452	of	abstract[24]	new[24]	_	_
5-4	453-460	quality	abstract[24]|abstract[25]	new[24]|giv[25]	_	_
5-5	461-463	of	abstract[24]|abstract[25]	new[24]|giv[25]	_	_
5-6	464-468	life	abstract[24]|abstract[25]|abstract|abstract[27]	new[24]|giv[25]|giv|new[27]	coref|coref|coref|coref	12-37|25-4[187_27]|12-37|25-4[187_27]
5-7	469-476	metrics	abstract[24]|abstract[25]|abstract[27]	new[24]|giv[25]|new[27]	_	_
5-8	477-480	has	_	_	_	_
5-9	481-487	become	_	_	_	_
5-10	488-500	particularly	_	_	_	_
5-11	501-510	important	_	_	_	_
5-12	511-513	in	_	_	_	_
5-13	514-517	the	abstract[28]	new[28]	_	_
5-14	518-529	examination	abstract[28]	new[28]	_	_
5-15	530-532	of	abstract[28]	new[28]	_	_
5-16	533-541	patients	abstract[28]|person[29]	new[28]|new[29]	coref	8-4[0_29]
5-17	542-546	with	abstract[28]|person[29]	new[28]|new[29]	_	_
5-18	547-551	mild	abstract[28]|person[29]|abstract[30]	new[28]|new[29]|new[30]	coref	6-21[0_30]
5-19	552-562	functional	abstract[28]|person[29]|abstract[30]	new[28]|new[29]|new[30]	_	_
5-20	563-573	impairment	abstract[28]|person[29]|abstract[30]	new[28]|new[29]|new[30]	_	_
5-21	574-575	(	abstract[28]|person[29]	new[28]|new[29]	_	_
5-22	576-578	or	abstract[28]|person[29]	new[28]|new[29]	_	_
5-23	579-591	asymptomatic	abstract[28]|person[29]|abstract[32]	new[28]|new[29]|new[32]	_	_
5-24	592-596	cord	abstract[28]|person[29]|object|abstract[32]	new[28]|new[29]|new|new[32]	_	_
5-25	597-608	compression	abstract[28]|person[29]|abstract[32]	new[28]|new[29]|new[32]	_	_
5-26	609-610	)	abstract[28]|person[29]	new[28]|new[29]	_	_
5-27	611-612	,	_	_	_	_
5-28	613-616	and	_	_	_	_
5-29	617-619	is	_	_	_	_
5-30	620-623	the	abstract[33]	giv[33]	_	_
5-31	624-629	focus	abstract[33]	giv[33]	_	_
5-32	630-632	of	abstract[33]	giv[33]	_	_
5-33	633-634	a	abstract[33]|abstract[34]	giv[33]|giv[34]	coref	7-9[52_34]
5-34	635-641	number	abstract[33]|abstract[34]	giv[33]|giv[34]	_	_
5-35	642-644	of	abstract[33]|abstract[34]	giv[33]|giv[34]	_	_
5-36	645-652	studies	abstract[33]|abstract[34]	giv[33]|giv[34]	_	_
5-37	653-654	.	_	_	_	_

#Text=Careful evaluation has discovered a number of predictors of clinical outcomes from surgery for DCM , including baseline severity of impairment , duration of symptoms , presence of systemic or psychological co-morbidities , obesity , and of course age .
6-1	655-662	Careful	abstract[35]	new[35]	_	_
6-2	663-673	evaluation	abstract[35]	new[35]	_	_
6-3	674-677	has	_	_	_	_
6-4	678-688	discovered	_	_	_	_
6-5	689-690	a	abstract[36]	new[36]	_	_
6-6	691-697	number	abstract[36]	new[36]	_	_
6-7	698-700	of	abstract[36]	new[36]	_	_
6-8	701-711	predictors	abstract[36]	new[36]	_	_
6-9	712-714	of	abstract[36]	new[36]	_	_
6-10	715-723	clinical	abstract[36]|abstract[37]	new[36]|giv[37]	coref	7-13[53_37]
6-11	724-732	outcomes	abstract[36]|abstract[37]	new[36]|giv[37]	_	_
6-12	733-737	from	abstract[36]	new[36]	_	_
6-13	738-745	surgery	abstract[36]|event[38]	new[36]|giv[38]	coref	7-22[55_38]
6-14	746-749	for	abstract[36]|event[38]	new[36]|giv[38]	_	_
6-15	750-753	DCM	abstract[36]|event[38]|abstract	new[36]|giv[38]|giv	coref	7-24
6-16	754-755	,	_	_	_	_
6-17	756-765	including	_	_	_	_
6-18	766-774	baseline	abstract[40]	new[40]	_	_
6-19	775-783	severity	abstract[40]	new[40]	_	_
6-20	784-786	of	abstract[40]	new[40]	_	_
6-21	787-797	impairment	abstract[40]|abstract	new[40]|giv	coref	12-20[88_0]
6-22	798-799	,	abstract[40]	new[40]	_	_
6-23	800-808	duration	abstract[40]|time[42]	new[40]|new[42]	coref	8-8[58_42]
6-24	809-811	of	abstract[40]|time[42]	new[40]|new[42]	_	_
6-25	812-820	symptoms	abstract[40]|time[42]|abstract	new[40]|new[42]|new	coref	8-14
6-26	821-822	,	abstract[40]	new[40]	_	_
6-27	823-831	presence	abstract[40]|abstract[44]	new[40]|new[44]	_	_
6-28	832-834	of	abstract[40]|abstract[44]	new[40]|new[44]	_	_
6-29	835-843	systemic	abstract[40]|abstract[44]|abstract[45]|abstract[46]	new[40]|new[44]|new[45]|new[46]	coref|coref|coref|coref	8-21[0_45]|12-7[82_46]|8-21[0_45]|12-7[82_46]
6-30	844-846	or	abstract[40]|abstract[44]|abstract[45]|abstract[46]	new[40]|new[44]|new[45]|new[46]	_	_
6-31	847-860	psychological	abstract[40]|abstract[44]|abstract[45]|abstract[46]	new[40]|new[44]|new[45]|new[46]	_	_
6-32	861-875	co-morbidities	abstract[40]|abstract[44]|abstract[45]|abstract[46]	new[40]|new[44]|new[45]|new[46]	_	_
6-33	876-877	,	abstract[40]|abstract[44]|abstract[46]	new[40]|new[44]|new[46]	_	_
6-34	878-885	obesity	abstract[40]|abstract[44]|abstract[46]|abstract	new[40]|new[44]|new[46]|new	_	_
6-35	886-887	,	abstract[40]|abstract[44]|abstract[46]	new[40]|new[44]|new[46]	_	_
6-36	888-891	and	abstract[40]|abstract[44]|abstract[46]	new[40]|new[44]|new[46]	_	_
6-37	892-894	of	abstract[40]|abstract[44]|abstract[46]	new[40]|new[44]|new[46]	_	_
6-38	895-901	course	abstract[40]|abstract[44]|abstract[46]|abstract[48]	new[40]|new[44]|new[46]|new[48]	coref	7-20[0_48]
6-39	902-905	age	abstract[40]|abstract[44]|abstract[46]|abstract[48]	new[40]|new[44]|new[46]|new[48]	_	_
6-40	906-907	.	_	_	_	_

#Text=With simple univariate analysis of outcome measures , many studies have reported worse functional and QOL outcomes with increasing age after surgery for DCM .
7-1	908-912	With	_	_	_	_
7-2	913-919	simple	abstract[49]	new[49]	_	_
7-3	920-930	univariate	abstract[49]	new[49]	_	_
7-4	931-939	analysis	abstract[49]	new[49]	_	_
7-5	940-942	of	abstract[49]	new[49]	_	_
7-6	943-950	outcome	abstract[49]|abstract|abstract[51]	new[49]|new|new[51]	_	_
7-7	951-959	measures	abstract[49]|abstract[51]	new[49]|new[51]	_	_
7-8	960-961	,	_	_	_	_
7-9	962-966	many	abstract[52]	giv[52]	coref	21-13[148_52]
7-10	967-974	studies	abstract[52]	giv[52]	_	_
7-11	975-979	have	_	_	_	_
7-12	980-988	reported	_	_	_	_
7-13	989-994	worse	abstract[53]	giv[53]	coref	26-17[204_53]
7-14	995-1005	functional	abstract[53]	giv[53]	_	_
7-15	1006-1009	and	abstract[53]	giv[53]	_	_
7-16	1010-1013	QOL	abstract[53]	giv[53]	_	_
7-17	1014-1022	outcomes	abstract[53]	giv[53]	_	_
7-18	1023-1027	with	_	_	_	_
7-19	1028-1038	increasing	_	_	_	_
7-20	1039-1042	age	abstract	giv	coref	14-9[99_0]
7-21	1043-1048	after	_	_	_	_
7-22	1049-1056	surgery	event[55]	giv[55]	coref	18-13[0_55]
7-23	1057-1060	for	event[55]	giv[55]	_	_
7-24	1061-1064	DCM	event[55]|abstract	giv[55]|giv	coref	10-1
7-25	1065-1066	.	_	_	_	_

#Text=However , elderly patients often present with increased duration and worse severity of symptoms , with an increased incidence of co-morbidities .
8-1	1067-1074	However	_	_	_	_
8-2	1075-1076	,	_	_	_	_
8-3	1077-1084	elderly	_	_	_	_
8-4	1085-1093	patients	person	giv	coref	9-1[63_0]
8-5	1094-1099	often	_	_	_	_
8-6	1100-1107	present	_	_	_	_
8-7	1108-1112	with	_	_	_	_
8-8	1113-1122	increased	time[58]	giv[58]	_	_
8-9	1123-1131	duration	time[58]	giv[58]	_	_
8-10	1132-1135	and	_	_	_	_
8-11	1136-1141	worse	abstract[59]	new[59]	_	_
8-12	1142-1150	severity	abstract[59]	new[59]	_	_
8-13	1151-1153	of	abstract[59]	new[59]	_	_
8-14	1154-1162	symptoms	abstract[59]|abstract	new[59]|giv	coref	12-11[84_0]
8-15	1163-1164	,	_	_	_	_
8-16	1165-1169	with	_	_	_	_
8-17	1170-1172	an	abstract[61]	new[61]	_	_
8-18	1173-1182	increased	abstract[61]	new[61]	_	_
8-19	1183-1192	incidence	abstract[61]	new[61]	_	_
8-20	1193-1195	of	abstract[61]	new[61]	_	_
8-21	1196-1210	co-morbidities	abstract[61]|abstract	new[61]|giv	coref	12-7
8-22	1211-1212	.	_	_	_	_

#Text=Many elderly patients also present a high , sometimes unacceptable , surgical risk profile that makes decisions regarding surgical management less appropriate .
9-1	1213-1217	Many	person[63]	giv[63]	coref	15-3[104_63]
9-2	1218-1225	elderly	person[63]	giv[63]	_	_
9-3	1226-1234	patients	person[63]	giv[63]	_	_
9-4	1235-1239	also	_	_	_	_
9-5	1240-1247	present	_	_	_	_
9-6	1248-1249	a	abstract[65]	new[65]	_	_
9-7	1250-1254	high	abstract[65]	new[65]	_	_
9-8	1255-1256	,	abstract[65]	new[65]	_	_
9-9	1257-1266	sometimes	abstract[65]	new[65]	_	_
9-10	1267-1279	unacceptable	abstract[65]	new[65]	_	_
9-11	1280-1281	,	abstract[65]	new[65]	_	_
9-12	1282-1290	surgical	abstract[65]	new[65]	_	_
9-13	1291-1295	risk	abstract|abstract[65]	new|new[65]	_	_
9-14	1296-1303	profile	abstract[65]	new[65]	_	_
9-15	1304-1308	that	_	_	_	_
9-16	1309-1314	makes	_	_	_	_
9-17	1315-1324	decisions	abstract	new	_	_
9-18	1325-1334	regarding	_	_	_	_
9-19	1335-1343	surgical	event[67]	new[67]	_	_
9-20	1344-1354	management	event[67]	new[67]	_	_
9-21	1355-1359	less	_	_	_	_
9-22	1360-1371	appropriate	_	_	_	_
9-23	1372-1373	.	_	_	_	_

#Text=DCM is a disease that can cause a significant amount of potentially reversible or preventable neurological disability in the elderly population , and therefore concerted efforts should be made to improve decision-making strategies for this patient group .
10-1	1374-1377	DCM	abstract	giv	coref	10-3[69_0]
10-2	1378-1380	is	_	_	_	_
10-3	1381-1382	a	abstract[69]	giv[69]	coref	14-16[0_69]
10-4	1383-1390	disease	abstract[69]	giv[69]	_	_
10-5	1391-1395	that	_	_	_	_
10-6	1396-1399	can	_	_	_	_
10-7	1400-1405	cause	_	_	_	_
10-8	1406-1407	a	abstract[70]	new[70]	_	_
10-9	1408-1419	significant	abstract[70]	new[70]	_	_
10-10	1420-1426	amount	abstract[70]	new[70]	_	_
10-11	1427-1429	of	abstract[70]	new[70]	_	_
10-12	1430-1441	potentially	abstract[70]|abstract[71]	new[70]|new[71]	coref	23-4[0_71]
10-13	1442-1452	reversible	abstract[70]|abstract[71]	new[70]|new[71]	_	_
10-14	1453-1455	or	abstract[70]|abstract[71]	new[70]|new[71]	_	_
10-15	1456-1467	preventable	abstract[70]|abstract[71]	new[70]|new[71]	_	_
10-16	1468-1480	neurological	abstract[70]|abstract[71]	new[70]|new[71]	_	_
10-17	1481-1491	disability	abstract[70]|abstract[71]	new[70]|new[71]	_	_
10-18	1492-1494	in	abstract[70]|abstract[71]	new[70]|new[71]	_	_
10-19	1495-1498	the	abstract[70]|abstract[71]|person[72]	new[70]|new[71]|new[72]	_	_
10-20	1499-1506	elderly	abstract[70]|abstract[71]|person[72]	new[70]|new[71]|new[72]	_	_
10-21	1507-1517	population	abstract[70]|abstract[71]|person[72]	new[70]|new[71]|new[72]	_	_
10-22	1518-1519	,	_	_	_	_
10-23	1520-1523	and	_	_	_	_
10-24	1524-1533	therefore	event[73]	new[73]	_	_
10-25	1534-1543	concerted	event[73]	new[73]	_	_
10-26	1544-1551	efforts	event[73]	new[73]	_	_
10-27	1552-1558	should	_	_	_	_
10-28	1559-1561	be	_	_	_	_
10-29	1562-1566	made	_	_	_	_
10-30	1567-1569	to	_	_	_	_
10-31	1570-1577	improve	_	_	_	_
10-32	1578-1593	decision-making	_	_	_	_
10-33	1594-1604	strategies	abstract[74]	new[74]	_	_
10-34	1605-1608	for	abstract[74]	new[74]	_	_
10-35	1609-1613	this	abstract[74]|person[75]	new[74]|new[75]	coref	24-24[183_75]
10-36	1614-1621	patient	abstract[74]|person[75]	new[74]|new[75]	_	_
10-37	1622-1627	group	abstract[74]|person[75]	new[74]|new[75]	_	_
10-38	1628-1629	.	_	_	_	_

#Text=The results of the current study demonstrate a number of important conclusions , some of which have not been described in previous literature .
11-1	1630-1633	The	abstract[76]	new[76]	_	_
11-2	1634-1641	results	abstract[76]	new[76]	_	_
11-3	1642-1644	of	abstract[76]	new[76]	_	_
11-4	1645-1648	the	abstract[76]|abstract[77]	new[76]|new[77]	coref	19-8[134_77]
11-5	1649-1656	current	abstract[76]|abstract[77]	new[76]|new[77]	_	_
11-6	1657-1662	study	abstract[76]|abstract[77]	new[76]|new[77]	_	_
11-7	1663-1674	demonstrate	_	_	_	_
11-8	1675-1676	a	abstract[78]	new[78]	ana	11-14[0_78]
11-9	1677-1683	number	abstract[78]	new[78]	_	_
11-10	1684-1686	of	abstract[78]	new[78]	_	_
11-11	1687-1696	important	abstract[78]	new[78]	_	_
11-12	1697-1708	conclusions	abstract[78]	new[78]	_	_
11-13	1709-1710	,	_	_	_	_
11-14	1711-1715	some	abstract	giv	_	_
11-15	1716-1718	of	_	_	_	_
11-16	1719-1724	which	_	_	_	_
11-17	1725-1729	have	_	_	_	_
11-18	1730-1733	not	_	_	_	_
11-19	1734-1738	been	_	_	_	_
11-20	1739-1748	described	_	_	_	_
11-21	1749-1751	in	_	_	_	_
11-22	1752-1760	previous	abstract[80]	new[80]	_	_
11-23	1761-1771	literature	abstract[80]	new[80]	_	_
11-24	1772-1773	.	_	_	_	_

#Text=Firstly , even when matched for co-morbidities , duration of symptoms , sex , smoking status and severity of functional impairment , younger adults report significantly worse effects on their baseline physical and mental quality of life scores compared to the older aged cohort .
12-1	1774-1781	Firstly	_	_	_	_
12-2	1782-1783	,	_	_	_	_
12-3	1784-1788	even	_	_	_	_
12-4	1789-1793	when	_	_	_	_
12-5	1794-1801	matched	_	_	_	_
12-6	1802-1805	for	_	_	_	_
12-7	1806-1820	co-morbidities	abstract|abstract[82]	giv|giv[82]	_	_
12-8	1821-1822	,	abstract[82]	giv[82]	_	_
12-9	1823-1831	duration	abstract[82]|time[83]	giv[82]|new[83]	_	_
12-10	1832-1834	of	abstract[82]|time[83]	giv[82]|new[83]	_	_
12-11	1835-1843	symptoms	abstract[82]|time[83]|abstract[84]	giv[82]|new[83]|giv[84]	_	_
12-12	1844-1845	,	abstract[82]|time[83]|abstract[84]	giv[82]|new[83]|giv[84]	_	_
12-13	1846-1849	sex	abstract[82]|time[83]|abstract[84]|abstract	giv[82]|new[83]|giv[84]|new	_	_
12-14	1850-1851	,	abstract[82]|time[83]|abstract[84]	giv[82]|new[83]|giv[84]	_	_
12-15	1852-1859	smoking	abstract[82]|time[83]|abstract[84]	giv[82]|new[83]|giv[84]	_	_
12-16	1860-1866	status	abstract[82]|time[83]|abstract[84]|abstract	giv[82]|new[83]|giv[84]|new	_	_
12-17	1867-1870	and	abstract[82]|time[83]|abstract[84]	giv[82]|new[83]|giv[84]	_	_
12-18	1871-1879	severity	abstract[82]|time[83]|abstract[84]|abstract[87]	giv[82]|new[83]|giv[84]|new[87]	_	_
12-19	1880-1882	of	abstract[82]|time[83]|abstract[84]|abstract[87]	giv[82]|new[83]|giv[84]|new[87]	_	_
12-20	1883-1893	functional	abstract[82]|time[83]|abstract[84]|abstract[87]|abstract[88]	giv[82]|new[83]|giv[84]|new[87]|giv[88]	coref	17-6[0_88]
12-21	1894-1904	impairment	abstract[82]|time[83]|abstract[84]|abstract[87]|abstract[88]	giv[82]|new[83]|giv[84]|new[87]|giv[88]	_	_
12-22	1905-1906	,	_	_	_	_
12-23	1907-1914	younger	person[89]	giv[89]	ana	12-30[0_89]
12-24	1915-1921	adults	person[89]	giv[89]	_	_
12-25	1922-1928	report	_	_	_	_
12-26	1929-1942	significantly	abstract[90]	new[90]	coref	29-3[229_90]
12-27	1943-1948	worse	abstract[90]	new[90]	_	_
12-28	1949-1956	effects	abstract[90]	new[90]	_	_
12-29	1957-1959	on	abstract[90]	new[90]	_	_
12-30	1960-1965	their	abstract[90]|person|abstract[92]	new[90]|giv|new[92]	ana|coref|ana|coref	13-1[0_92]|22-41[161_0]|13-1[0_92]|22-41[161_0]
12-31	1966-1974	baseline	abstract[90]|abstract[92]	new[90]|new[92]	_	_
12-32	1975-1983	physical	abstract[90]|abstract[92]	new[90]|new[92]	_	_
12-33	1984-1987	and	abstract[90]|abstract[92]	new[90]|new[92]	_	_
12-34	1988-1994	mental	abstract[90]|abstract[92]	new[90]|new[92]	_	_
12-35	1995-2002	quality	abstract[90]|abstract[92]	new[90]|new[92]	_	_
12-36	2003-2005	of	abstract[90]|abstract[92]	new[90]|new[92]	_	_
12-37	2006-2010	life	abstract[90]|abstract[92]|abstract|abstract[94]	new[90]|new[92]|giv|new[94]	coref|coref|coref|coref	15-26|17-4[120_94]|15-26|17-4[120_94]
12-38	2011-2017	scores	abstract[90]|abstract[92]|abstract[94]	new[90]|new[92]|new[94]	_	_
12-39	2018-2026	compared	_	_	_	_
12-40	2027-2029	to	_	_	_	_
12-41	2030-2033	the	person[95]	new[95]	coref	18-2[124_95]
12-42	2034-2039	older	person[95]	new[95]	_	_
12-43	2040-2044	aged	person[95]	new[95]	_	_
12-44	2045-2051	cohort	person[95]	new[95]	_	_
12-45	2052-2053	.	_	_	_	_

#Text=This could be explained through 2 potential mechanisms .
13-1	2054-2058	This	abstract	giv	_	_
13-2	2059-2064	could	_	_	_	_
13-3	2065-2067	be	_	_	_	_
13-4	2068-2077	explained	_	_	_	_
13-5	2078-2085	through	_	_	_	_
13-6	2086-2087	2	abstract[97]	new[97]	coref	22-1[149_97]
13-7	2088-2097	potential	abstract[97]	new[97]	_	_
13-8	2098-2108	mechanisms	abstract[97]	new[97]	_	_
13-9	2109-2110	.	_	_	_	_

#Text=Firstly , as the younger cohort were of working age , the psychological impact of DCM may be greater if employment security is perceived to be threatened .
14-1	2111-2118	Firstly	_	_	_	_
14-2	2119-2120	,	_	_	_	_
14-3	2121-2123	as	_	_	_	_
14-4	2124-2127	the	person[98]	new[98]	coref	25-12[189_98]
14-5	2128-2135	younger	person[98]	new[98]	_	_
14-6	2136-2142	cohort	person[98]	new[98]	_	_
14-7	2143-2147	were	_	_	_	_
14-8	2148-2150	of	_	_	_	_
14-9	2151-2158	working	abstract[99]	giv[99]	coref	23-28[0_99]
14-10	2159-2162	age	abstract[99]	giv[99]	_	_
14-11	2163-2164	,	_	_	_	_
14-12	2165-2168	the	abstract[100]	new[100]	_	_
14-13	2169-2182	psychological	abstract[100]	new[100]	_	_
14-14	2183-2189	impact	abstract[100]	new[100]	_	_
14-15	2190-2192	of	abstract[100]	new[100]	_	_
14-16	2193-2196	DCM	abstract[100]|abstract	new[100]|giv	coref	15-16
14-17	2197-2200	may	_	_	_	_
14-18	2201-2203	be	_	_	_	_
14-19	2204-2211	greater	_	_	_	_
14-20	2212-2214	if	_	_	_	_
14-21	2215-2225	employment	abstract|abstract[103]	new|new[103]	_	_
14-22	2226-2234	security	abstract[103]	new[103]	_	_
14-23	2235-2237	is	_	_	_	_
14-24	2238-2247	perceived	_	_	_	_
14-25	2248-2250	to	_	_	_	_
14-26	2251-2253	be	_	_	_	_
14-27	2254-2264	threatened	_	_	_	_
14-28	2265-2266	.	_	_	_	_

#Text=Secondly , the elderly patients demonstrate psychological resilience or adaptations/support that mean the symptoms of DCM have a less pronounced effect on their quality of life .
15-1	2267-2275	Secondly	_	_	_	_
15-2	2276-2277	,	_	_	_	_
15-3	2278-2281	the	person[104]	giv[104]	ana	15-23[0_104]
15-4	2282-2289	elderly	person[104]	giv[104]	_	_
15-5	2290-2298	patients	person[104]	giv[104]	_	_
15-6	2299-2310	demonstrate	_	_	_	_
15-7	2311-2324	psychological	abstract[105]	new[105]	_	_
15-8	2325-2335	resilience	abstract[105]	new[105]	_	_
15-9	2336-2338	or	_	_	_	_
15-10	2339-2358	adaptations/support	abstract	new	_	_
15-11	2359-2363	that	_	_	_	_
15-12	2364-2368	mean	_	_	_	_
15-13	2369-2372	the	abstract[107]	new[107]	coref	22-18[154_107]
15-14	2373-2381	symptoms	abstract[107]	new[107]	_	_
15-15	2382-2384	of	abstract[107]	new[107]	_	_
15-16	2385-2388	DCM	abstract[107]|abstract	new[107]|giv	coref	26-25
15-17	2389-2393	have	_	_	_	_
15-18	2394-2395	a	abstract[109]	new[109]	_	_
15-19	2396-2400	less	abstract[109]	new[109]	_	_
15-20	2401-2411	pronounced	abstract[109]	new[109]	_	_
15-21	2412-2418	effect	abstract[109]	new[109]	_	_
15-22	2419-2421	on	abstract[109]	new[109]	_	_
15-23	2422-2427	their	abstract[109]|person|abstract[111]	new[109]|giv|new[111]	coref|coref	16-15[117_0]|16-15[117_0]
15-24	2428-2435	quality	abstract[109]|abstract[111]	new[109]|new[111]	_	_
15-25	2436-2438	of	abstract[109]|abstract[111]	new[109]|new[111]	_	_
15-26	2439-2443	life	abstract[109]|abstract[111]|abstract	new[109]|new[111]|giv	ana	16-1
15-27	2444-2445	.	_	_	_	_

#Text=This is an interesting concept , and is an important consideration for clinicians managing elderly DCM patients .
16-1	2446-2450	This	abstract	giv	coref	16-3[114_0]
16-2	2451-2453	is	_	_	_	_
16-3	2454-2456	an	abstract[114]	giv[114]	coref	26-17[0_114]
16-4	2457-2468	interesting	abstract[114]	giv[114]	_	_
16-5	2469-2476	concept	abstract[114]	giv[114]	_	_
16-6	2477-2478	,	abstract[114]	giv[114]	_	_
16-7	2479-2482	and	abstract[114]	giv[114]	_	_
16-8	2483-2485	is	abstract[114]	giv[114]	_	_
16-9	2486-2488	an	abstract[114]|abstract[115]	giv[114]|new[115]	_	_
16-10	2489-2498	important	abstract[114]|abstract[115]	giv[114]|new[115]	_	_
16-11	2499-2512	consideration	abstract[114]|abstract[115]	giv[114]|new[115]	_	_
16-12	2513-2516	for	abstract[114]|abstract[115]	giv[114]|new[115]	_	_
16-13	2517-2527	clinicians	abstract[114]|abstract[115]|person	giv[114]|new[115]|new	_	_
16-14	2528-2536	managing	_	_	_	_
16-15	2537-2544	elderly	person[117]	giv[117]	coref	17-1[118_117]
16-16	2545-2548	DCM	person[117]	giv[117]	_	_
16-17	2549-2557	patients	person[117]	giv[117]	_	_
16-18	2558-2559	.	_	_	_	_

#Text=All patients showed improved functional impairment scores after 2 years ( see Table 2 ) .
17-1	2560-2563	All	person[118]	giv[118]	coref	18-23[131_118]
17-2	2564-2572	patients	person[118]	giv[118]	_	_
17-3	2573-2579	showed	_	_	_	_
17-4	2580-2588	improved	abstract[120]	giv[120]	coref	20-5[137_120]
17-5	2589-2599	functional	abstract[120]	giv[120]	_	_
17-6	2600-2610	impairment	abstract|abstract[120]	giv|giv[120]	_	_
17-7	2611-2617	scores	abstract[120]	giv[120]	_	_
17-8	2618-2623	after	_	_	_	_
17-9	2624-2625	2	time[121]	new[121]	coref	20-8[138_121]
17-10	2626-2631	years	time[121]	new[121]	_	_
17-11	2632-2633	(	_	_	_	_
17-12	2634-2637	see	_	_	_	_
17-13	2638-2643	Table	abstract	new	_	_
17-14	2644-2645	2	quantity	new	_	_
17-15	2646-2647	)	_	_	_	_
17-16	2648-2649	.	_	_	_	_

#Text=Taking the older cohort in isolation , this is good evidence that surgery is an effective modality to produce functional improvements in elderly DCM patients .
18-1	2650-2656	Taking	_	_	_	_
18-2	2657-2660	the	person[124]	giv[124]	coref	20-33[144_124]
18-3	2661-2666	older	person[124]	giv[124]	_	_
18-4	2667-2673	cohort	person[124]	giv[124]	_	_
18-5	2674-2676	in	person[124]	giv[124]	_	_
18-6	2677-2686	isolation	person[124]|abstract	giv[124]|new	ana	18-8
18-7	2687-2688	,	_	_	_	_
18-8	2689-2693	this	abstract	giv	coref	18-10[127_0]
18-9	2694-2696	is	_	_	_	_
18-10	2697-2701	good	abstract[127]	giv[127]	coref	26-3[199_127]
18-11	2702-2710	evidence	abstract[127]	giv[127]	_	_
18-12	2711-2715	that	abstract[127]	giv[127]	_	_
18-13	2716-2723	surgery	abstract[127]|event	giv[127]|giv	coref	18-15[129_0]
18-14	2724-2726	is	abstract[127]	giv[127]	_	_
18-15	2727-2729	an	abstract[127]|event[129]	giv[127]|giv[129]	ana	19-1[0_129]
18-16	2730-2739	effective	abstract[127]|event[129]	giv[127]|giv[129]	_	_
18-17	2740-2748	modality	abstract[127]|event[129]	giv[127]|giv[129]	_	_
18-18	2749-2751	to	_	_	_	_
18-19	2752-2759	produce	_	_	_	_
18-20	2760-2770	functional	abstract[130]	new[130]	_	_
18-21	2771-2783	improvements	abstract[130]	new[130]	_	_
18-22	2784-2786	in	_	_	_	_
18-23	2787-2794	elderly	person[131]	giv[131]	coref	20-29[143_131]
18-24	2795-2798	DCM	person[131]	giv[131]	_	_
18-25	2799-2807	patients	person[131]	giv[131]	_	_
18-26	2808-2809	.	_	_	_	_

#Text=This is an important stand-alone conclusion from this study .
19-1	2810-2814	This	event	giv	coref	19-3[133_0]
19-2	2815-2817	is	_	_	_	_
19-3	2818-2820	an	event[133]	giv[133]	coref	20-22[0_133]
19-4	2821-2830	important	event[133]	giv[133]	_	_
19-5	2831-2842	stand-alone	event[133]	giv[133]	_	_
19-6	2843-2853	conclusion	event[133]	giv[133]	_	_
19-7	2854-2858	from	event[133]	giv[133]	_	_
19-8	2859-2863	this	event[133]|abstract[134]	giv[133]|giv[134]	coref	28-1[219_134]
19-9	2864-2869	study	event[133]|abstract[134]	giv[133]|giv[134]	_	_
19-10	2870-2871	.	_	_	_	_

#Text=When the change from baseline scores at 2 years is calculated , it becomes evident that the functional improvement seen after surgery is of a greater magnitude in younger patients compared to the older cohort .
20-1	2872-2876	When	_	_	_	_
20-2	2877-2880	the	abstract[135]	new[135]	ana	20-13[0_135]
20-3	2881-2887	change	abstract[135]	new[135]	_	_
20-4	2888-2892	from	abstract[135]	new[135]	_	_
20-5	2893-2901	baseline	abstract[135]|abstract|abstract[137]	new[135]|new|giv[137]	ana|coref|ana|coref	21-6[0_137]|24-10[178_0]|21-6[0_137]|24-10[178_0]
20-6	2902-2908	scores	abstract[135]|abstract[137]	new[135]|giv[137]	_	_
20-7	2909-2911	at	abstract[135]|abstract[137]	new[135]|giv[137]	_	_
20-8	2912-2913	2	abstract[135]|abstract[137]|time[138]	new[135]|giv[137]|giv[138]	_	_
20-9	2914-2919	years	abstract[135]|abstract[137]|time[138]	new[135]|giv[137]|giv[138]	_	_
20-10	2920-2922	is	_	_	_	_
20-11	2923-2933	calculated	_	_	_	_
20-12	2934-2935	,	_	_	_	_
20-13	2936-2938	it	abstract	giv	_	_
20-14	2939-2946	becomes	_	_	_	_
20-15	2947-2954	evident	_	_	_	_
20-16	2955-2959	that	_	_	_	_
20-17	2960-2963	the	abstract[140]	giv[140]	coref	25-7[188_140]
20-18	2964-2974	functional	abstract[140]	giv[140]	_	_
20-19	2975-2986	improvement	abstract[140]	giv[140]	_	_
20-20	2987-2991	seen	_	_	_	_
20-21	2992-2997	after	_	_	_	_
20-22	2998-3005	surgery	event	giv	coref	21-1[145_0]
20-23	3006-3008	is	_	_	_	_
20-24	3009-3011	of	_	_	_	_
20-25	3012-3013	a	abstract[142]	new[142]	coref	23-23[0_142]
20-26	3014-3021	greater	abstract[142]	new[142]	_	_
20-27	3022-3031	magnitude	abstract[142]	new[142]	_	_
20-28	3032-3034	in	abstract[142]	new[142]	_	_
20-29	3035-3042	younger	abstract[142]|person[143]	new[142]|giv[143]	coref	22-11[0_143]
20-30	3043-3051	patients	abstract[142]|person[143]	new[142]|giv[143]	_	_
20-31	3052-3060	compared	_	_	_	_
20-32	3061-3063	to	_	_	_	_
20-33	3064-3067	the	person[144]	giv[144]	coref	25-26[193_144]
20-34	3068-3073	older	person[144]	giv[144]	_	_
20-35	3074-3080	cohort	person[144]	giv[144]	_	_
20-36	3081-3082	.	_	_	_	_

#Text=This conclusion is similar to those described from previous univariate analyses in prior studies .
21-1	3083-3087	This	event[145]	giv[145]	coref	23-14[165_145]
21-2	3088-3098	conclusion	event[145]	giv[145]	_	_
21-3	3099-3101	is	_	_	_	_
21-4	3102-3109	similar	_	_	_	_
21-5	3110-3112	to	_	_	_	_
21-6	3113-3118	those	abstract	giv	coref	24-20[182_0]
21-7	3119-3128	described	_	_	_	_
21-8	3129-3133	from	_	_	_	_
21-9	3134-3142	previous	abstract[147]	new[147]	_	_
21-10	3143-3153	univariate	abstract[147]	new[147]	_	_
21-11	3154-3162	analyses	abstract[147]	new[147]	_	_
21-12	3163-3165	in	abstract[147]	new[147]	_	_
21-13	3166-3171	prior	abstract[147]|abstract[148]	new[147]|giv[148]	_	_
21-14	3172-3179	studies	abstract[147]|abstract[148]	new[147]|giv[148]	_	_
21-15	3180-3181	.	_	_	_	_

#Text=Suggested mechanisms for this discrepancy include the fact that elderly patients often present with increased duration of symptoms at diagnosis , often have difficulty accessing specialist assessment and imaging , and also have less neurological plasticity or reserve compared to younger adults .
22-1	3182-3191	Suggested	abstract[149]	giv[149]	_	_
22-2	3192-3202	mechanisms	abstract[149]	giv[149]	_	_
22-3	3203-3206	for	abstract[149]	giv[149]	_	_
22-4	3207-3211	this	abstract[149]|abstract[150]	giv[149]|new[150]	_	_
22-5	3212-3223	discrepancy	abstract[149]|abstract[150]	giv[149]|new[150]	_	_
22-6	3224-3231	include	_	_	_	_
22-7	3232-3235	the	abstract[151]	new[151]	_	_
22-8	3236-3240	fact	abstract[151]	new[151]	_	_
22-9	3241-3245	that	abstract[151]	new[151]	_	_
22-10	3246-3253	elderly	abstract[151]	new[151]	_	_
22-11	3254-3262	patients	abstract[151]|person	new[151]|giv	coref	23-16[166_0]
22-12	3263-3268	often	abstract[151]	new[151]	_	_
22-13	3269-3276	present	abstract[151]	new[151]	_	_
22-14	3277-3281	with	_	_	_	_
22-15	3282-3291	increased	time[153]	new[153]	_	_
22-16	3292-3300	duration	time[153]	new[153]	_	_
22-17	3301-3303	of	time[153]	new[153]	_	_
22-18	3304-3312	symptoms	time[153]|abstract[154]	new[153]|giv[154]	_	_
22-19	3313-3315	at	time[153]|abstract[154]	new[153]|giv[154]	_	_
22-20	3316-3325	diagnosis	time[153]|abstract[154]|event	new[153]|giv[154]|new	_	_
22-21	3326-3327	,	_	_	_	_
22-22	3328-3333	often	_	_	_	_
22-23	3334-3338	have	_	_	_	_
22-24	3339-3349	difficulty	abstract	new	_	_
22-25	3350-3359	accessing	_	_	_	_
22-26	3360-3370	specialist	abstract[157]	giv[157]	coref	28-27[226_157]
22-27	3371-3381	assessment	abstract[157]	giv[157]	_	_
22-28	3382-3385	and	_	_	_	_
22-29	3386-3393	imaging	event	new	_	_
22-30	3394-3395	,	_	_	_	_
22-31	3396-3399	and	_	_	_	_
22-32	3400-3404	also	_	_	_	_
22-33	3405-3409	have	_	_	_	_
22-34	3410-3414	less	abstract[159]	new[159]	_	_
22-35	3415-3427	neurological	abstract[159]	new[159]	_	_
22-36	3428-3438	plasticity	abstract[159]	new[159]	_	_
22-37	3439-3441	or	_	_	_	_
22-38	3442-3449	reserve	abstract	new	_	_
22-39	3450-3458	compared	_	_	_	_
22-40	3459-3461	to	_	_	_	_
22-41	3462-3469	younger	person[161]	giv[161]	_	_
22-42	3470-3476	adults	person[161]	giv[161]	_	_
22-43	3477-3478	.	_	_	_	_

#Text=The level of disability as measured by the NDI was improved significantly by surgery for all patients , but the order of magnitude was similar for both age groups ( p = 0.094 ) .
23-1	3479-3482	The	abstract[162]	new[162]	_	_
23-2	3483-3488	level	abstract[162]	new[162]	_	_
23-3	3489-3491	of	abstract[162]	new[162]	_	_
23-4	3492-3502	disability	abstract[162]|abstract	new[162]|giv	_	_
23-5	3503-3505	as	_	_	_	_
23-6	3506-3514	measured	_	_	_	_
23-7	3515-3517	by	_	_	_	_
23-8	3518-3521	the	abstract[164]	new[164]	_	_
23-9	3522-3525	NDI	abstract[164]	new[164]	_	_
23-10	3526-3529	was	_	_	_	_
23-11	3530-3538	improved	_	_	_	_
23-12	3539-3552	significantly	_	_	_	_
23-13	3553-3555	by	_	_	_	_
23-14	3556-3563	surgery	event[165]	giv[165]	coref	26-6[0_165]
23-15	3564-3567	for	event[165]	giv[165]	_	_
23-16	3568-3571	all	event[165]|person[166]	giv[165]|giv[166]	coref	24-1[173_166]
23-17	3572-3580	patients	event[165]|person[166]	giv[165]|giv[166]	_	_
23-18	3581-3582	,	_	_	_	_
23-19	3583-3586	but	_	_	_	_
23-20	3587-3590	the	quantity[167]	new[167]	_	_
23-21	3591-3596	order	quantity[167]	new[167]	_	_
23-22	3597-3599	of	quantity[167]	new[167]	_	_
23-23	3600-3609	magnitude	quantity[167]|abstract	new[167]|giv	coref	27-28[215_0]
23-24	3610-3613	was	_	_	_	_
23-25	3614-3621	similar	_	_	_	_
23-26	3622-3625	for	_	_	_	_
23-27	3626-3630	both	abstract[170]	new[170]	_	_
23-28	3631-3634	age	abstract|abstract[170]	giv|new[170]	_	_
23-29	3635-3641	groups	abstract[170]	new[170]	_	_
23-30	3642-3643	(	_	_	_	_
23-31	3644-3645	p	quantity	new	coref	25-30
23-32	3646-3647	=	_	_	_	_
23-33	3648-3653	0.094	quantity	new	_	_
23-34	3654-3655	)	_	_	_	_
23-35	3656-3657	.	_	_	_	_

#Text=All patients demonstrated improved SF-36 PCS and MCS from baseline at the 2-year interval , with the exception of the MCS scores in the elderly group .
24-1	3658-3661	All	person[173]	giv[173]	coref	26-20[205_173]
24-2	3662-3670	patients	person[173]	giv[173]	_	_
24-3	3671-3683	demonstrated	_	_	_	_
24-4	3684-3692	improved	abstract[174]|organization[175]|abstract[176]	new[174]|new[175]|new[176]	coref|coref|coref|coref|coref|coref|coref|coref|coref	25-1[184_175]|25-1[185_176]|29-14[0_174]|25-1[184_175]|25-1[185_176]|29-14[0_174]|25-1[184_175]|25-1[185_176]|29-14[0_174]
24-5	3693-3698	SF-36	abstract[174]|organization[175]|abstract[176]	new[174]|new[175]|new[176]	_	_
24-6	3699-3702	PCS	abstract[174]|organization[175]|abstract[176]	new[174]|new[175]|new[176]	_	_
24-7	3703-3706	and	abstract[174]|abstract[176]	new[174]|new[176]	_	_
24-8	3707-3710	MCS	abstract[174]|abstract[176]|abstract[177]	new[174]|new[176]|new[177]	coref	24-21[0_177]
24-9	3711-3715	from	abstract[174]|abstract[176]|abstract[177]	new[174]|new[176]|new[177]	_	_
24-10	3716-3724	baseline	abstract[174]|abstract[176]|abstract[177]|abstract[178]	new[174]|new[176]|new[177]|giv[178]	coref	25-23[0_178]
24-11	3725-3727	at	abstract[174]|abstract[176]|abstract[177]|abstract[178]	new[174]|new[176]|new[177]|giv[178]	_	_
24-12	3728-3731	the	abstract[174]|abstract[176]|abstract[177]|abstract[178]|time[179]	new[174]|new[176]|new[177]|giv[178]|new[179]	_	_
24-13	3732-3738	2-year	abstract[174]|abstract[176]|abstract[177]|abstract[178]|time[179]	new[174]|new[176]|new[177]|giv[178]|new[179]	_	_
24-14	3739-3747	interval	abstract[174]|abstract[176]|abstract[177]|abstract[178]|time[179]	new[174]|new[176]|new[177]|giv[178]|new[179]	_	_
24-15	3748-3749	,	abstract[174]	new[174]	_	_
24-16	3750-3754	with	abstract[174]	new[174]	_	_
24-17	3755-3758	the	abstract[174]|abstract[180]	new[174]|new[180]	_	_
24-18	3759-3768	exception	abstract[174]|abstract[180]	new[174]|new[180]	_	_
24-19	3769-3771	of	abstract[174]|abstract[180]	new[174]|new[180]	_	_
24-20	3772-3775	the	abstract[174]|abstract[180]|abstract[182]	new[174]|new[180]|giv[182]	_	_
24-21	3776-3779	MCS	abstract[174]|abstract[180]|abstract|abstract[182]	new[174]|new[180]|giv|giv[182]	coref	25-4
24-22	3780-3786	scores	abstract[174]|abstract[180]|abstract[182]	new[174]|new[180]|giv[182]	_	_
24-23	3787-3789	in	abstract[174]|abstract[180]|abstract[182]	new[174]|new[180]|giv[182]	_	_
24-24	3790-3793	the	abstract[174]|abstract[180]|abstract[182]|person[183]	new[174]|new[180]|giv[182]|giv[183]	_	_
24-25	3794-3801	elderly	abstract[174]|abstract[180]|abstract[182]|person[183]	new[174]|new[180]|giv[182]|giv[183]	_	_
24-26	3802-3807	group	abstract[174]|abstract[180]|abstract[182]|person[183]	new[174]|new[180]|giv[182]|giv[183]	_	_
24-27	3808-3809	.	_	_	_	_

#Text=Both PCS and MCS metrics echoed the functional improvement in that the younger cohort had a significantly greater degree of improvement from baseline compared to the older cohort ( p < 0.001 , p = 0.007 ) .
25-1	3810-3814	Both	organization[184]|abstract[185]	giv[184]|giv[185]	_	_
25-2	3815-3818	PCS	organization[184]|abstract[185]	giv[184]|giv[185]	_	_
25-3	3819-3822	and	abstract[185]	giv[185]	_	_
25-4	3823-3826	MCS	abstract[185]|abstract|abstract[187]	giv[185]|giv|giv[187]	_	_
25-5	3827-3834	metrics	abstract[185]|abstract[187]	giv[185]|giv[187]	_	_
25-6	3835-3841	echoed	_	_	_	_
25-7	3842-3845	the	abstract[188]	giv[188]	coref	25-21[191_188]
25-8	3846-3856	functional	abstract[188]	giv[188]	_	_
25-9	3857-3868	improvement	abstract[188]	giv[188]	_	_
25-10	3869-3871	in	_	_	_	_
25-11	3872-3876	that	_	_	_	_
25-12	3877-3880	the	person[189]	giv[189]	_	_
25-13	3881-3888	younger	person[189]	giv[189]	_	_
25-14	3889-3895	cohort	person[189]	giv[189]	_	_
25-15	3896-3899	had	_	_	_	_
25-16	3900-3901	a	abstract[190]	new[190]	_	_
25-17	3902-3915	significantly	abstract[190]	new[190]	_	_
25-18	3916-3923	greater	abstract[190]	new[190]	_	_
25-19	3924-3930	degree	abstract[190]	new[190]	_	_
25-20	3931-3933	of	abstract[190]	new[190]	_	_
25-21	3934-3945	improvement	abstract[190]|abstract[191]	new[190]|giv[191]	coref	27-22[214_191]
25-22	3946-3950	from	abstract[190]|abstract[191]	new[190]|giv[191]	_	_
25-23	3951-3959	baseline	abstract[190]|abstract[191]|abstract	new[190]|giv[191]|giv	ana	26-1
25-24	3960-3968	compared	_	_	_	_
25-25	3969-3971	to	_	_	_	_
25-26	3972-3975	the	person[193]	giv[193]	_	_
25-27	3976-3981	older	person[193]	giv[193]	_	_
25-28	3982-3988	cohort	person[193]	giv[193]	_	_
25-29	3989-3990	(	_	_	_	_
25-30	3991-3992	p	quantity	giv	coref	25-34
25-31	3993-3994	<	_	_	_	_
25-32	3995-4000	0.001	quantity	new	_	_
25-33	4001-4002	,	_	_	_	_
25-34	4003-4004	p	quantity	giv	_	_
25-35	4005-4006	=	_	_	_	_
25-36	4007-4012	0.007	quantity	new	_	_
25-37	4013-4014	)	_	_	_	_
25-38	4015-4016	.	_	_	_	_

#Text=This provides good evidence that surgery leads to increased physical and mental perception of quality of life outcomes in all patients undergoing surgery for DCM .
26-1	4017-4021	This	abstract	giv	_	_
26-2	4022-4030	provides	_	_	_	_
26-3	4031-4035	good	abstract[199]	giv[199]	_	_
26-4	4036-4044	evidence	abstract[199]	giv[199]	_	_
26-5	4045-4049	that	_	_	_	_
26-6	4050-4057	surgery	event	giv	coref	26-23
26-7	4058-4063	leads	_	_	_	_
26-8	4064-4066	to	_	_	_	_
26-9	4067-4076	increased	abstract[201]	new[201]	_	_
26-10	4077-4085	physical	abstract[201]	new[201]	_	_
26-11	4086-4089	and	abstract[201]	new[201]	_	_
26-12	4090-4096	mental	abstract[201]	new[201]	_	_
26-13	4097-4107	perception	abstract[201]	new[201]	_	_
26-14	4108-4110	of	abstract[201]	new[201]	_	_
26-15	4111-4118	quality	abstract[201]|abstract[202]	new[201]|new[202]	_	_
26-16	4119-4121	of	abstract[201]|abstract[202]	new[201]|new[202]	_	_
26-17	4122-4126	life	abstract[201]|abstract[202]|abstract|abstract[204]	new[201]|new[202]|giv|giv[204]	coref|coref	27-12|27-12
26-18	4127-4135	outcomes	abstract[201]|abstract[202]|abstract[204]	new[201]|new[202]|giv[204]	_	_
26-19	4136-4138	in	abstract[201]|abstract[202]|abstract[204]	new[201]|new[202]|giv[204]	_	_
26-20	4139-4142	all	abstract[201]|abstract[202]|abstract[204]|person[205]	new[201]|new[202]|giv[204]|giv[205]	_	_
26-21	4143-4151	patients	abstract[201]|abstract[202]|abstract[204]|person[205]	new[201]|new[202]|giv[204]|giv[205]	_	_
26-22	4152-4162	undergoing	_	_	_	_
26-23	4163-4170	surgery	event	giv	_	_
26-24	4171-4174	for	_	_	_	_
26-25	4175-4178	DCM	abstract	giv	coref	28-35
26-26	4179-4180	.	_	_	_	_

#Text=It appears that older patients ’ mental perception of quality of life remains stable throughout the treatment period , despite having a worse functional improvement , and less magnitude of quality of life improvement overall .
27-1	4181-4183	It	_	_	_	_
27-2	4184-4191	appears	_	_	_	_
27-3	4192-4196	that	_	_	_	_
27-4	4197-4202	older	person[208]|abstract[209]	new[208]|new[209]	coref|coref|coref|coref	28-32[227_208]|29-6[231_209]|28-32[227_208]|29-6[231_209]
27-5	4203-4211	patients	person[208]|abstract[209]	new[208]|new[209]	_	_
27-6	4212-4213	’	person[208]|abstract[209]	new[208]|new[209]	_	_
27-7	4214-4220	mental	abstract[209]	new[209]	_	_
27-8	4221-4231	perception	abstract[209]	new[209]	_	_
27-9	4232-4234	of	abstract[209]	new[209]	_	_
27-10	4235-4242	quality	abstract[209]|abstract[210]	new[209]|new[210]	_	_
27-11	4243-4245	of	abstract[209]|abstract[210]	new[209]|new[210]	_	_
27-12	4246-4250	life	abstract[209]|abstract[210]|time	new[209]|new[210]|giv	coref	27-16[213_0]
27-13	4251-4258	remains	_	_	_	_
27-14	4259-4265	stable	_	_	_	_
27-15	4266-4276	throughout	_	_	_	_
27-16	4277-4280	the	time[213]	giv[213]	coref	27-33[0_213]
27-17	4281-4290	treatment	event|time[213]	new|giv[213]	_	_
27-18	4291-4297	period	time[213]	giv[213]	_	_
27-19	4298-4299	,	_	_	_	_
27-20	4300-4307	despite	_	_	_	_
27-21	4308-4314	having	_	_	_	_
27-22	4315-4316	a	abstract[214]	giv[214]	coref	27-34[0_214]
27-23	4317-4322	worse	abstract[214]	giv[214]	_	_
27-24	4323-4333	functional	abstract[214]	giv[214]	_	_
27-25	4334-4345	improvement	abstract[214]	giv[214]	_	_
27-26	4346-4347	,	_	_	_	_
27-27	4348-4351	and	_	_	_	_
27-28	4352-4356	less	abstract[215]	giv[215]	_	_
27-29	4357-4366	magnitude	abstract[215]	giv[215]	_	_
27-30	4367-4369	of	abstract[215]	giv[215]	_	_
27-31	4370-4377	quality	abstract[215]|abstract[216]	giv[215]|new[216]	_	_
27-32	4378-4380	of	abstract[215]|abstract[216]	giv[215]|new[216]	_	_
27-33	4381-4385	life	abstract[215]|abstract[216]|abstract	giv[215]|new[216]|giv	coref	28-13
27-34	4386-4397	improvement	abstract[215]|abstract[216]|abstract	giv[215]|new[216]|giv	_	_
27-35	4398-4405	overall	abstract[215]|abstract[216]	giv[215]|new[216]	_	_
27-36	4406-4407	.	_	_	_	_

#Text=This study is the first to report this difference in quality of life measures between younger and older aged cohorts and has potentially large implications on pre-surgical assessment and counselling in older patients with DCM .
28-1	4408-4412	This	abstract[219]	giv[219]	coref	31-26[257_219]
28-2	4413-4418	study	abstract[219]	giv[219]	_	_
28-3	4419-4421	is	_	_	_	_
28-4	4422-4425	the	_	_	_	_
28-5	4426-4431	first	_	_	_	_
28-6	4432-4434	to	_	_	_	_
28-7	4435-4441	report	_	_	_	_
28-8	4442-4446	this	abstract[220]	new[220]	_	_
28-9	4447-4457	difference	abstract[220]	new[220]	_	_
28-10	4458-4460	in	abstract[220]	new[220]	_	_
28-11	4461-4468	quality	abstract[220]|abstract[221]	new[220]|new[221]	_	_
28-12	4469-4471	of	abstract[220]|abstract[221]	new[220]|new[221]	_	_
28-13	4472-4476	life	abstract[220]|abstract[221]|abstract|abstract[223]	new[220]|new[221]|giv|new[223]	coref|coref|coref|coref	29-37|31-10[253_223]|29-37|31-10[253_223]
28-14	4477-4485	measures	abstract[220]|abstract[221]|abstract[223]	new[220]|new[221]|new[223]	_	_
28-15	4486-4493	between	abstract[220]|abstract[221]|abstract[223]	new[220]|new[221]|new[223]	_	_
28-16	4494-4501	younger	abstract[220]|abstract[221]|abstract[223]|person[224]	new[220]|new[221]|new[223]|new[224]	_	_
28-17	4502-4505	and	abstract[220]|abstract[221]|abstract[223]|person[224]	new[220]|new[221]|new[223]|new[224]	_	_
28-18	4506-4511	older	abstract[220]|abstract[221]|abstract[223]|person[224]	new[220]|new[221]|new[223]|new[224]	_	_
28-19	4512-4516	aged	abstract[220]|abstract[221]|abstract[223]|person[224]	new[220]|new[221]|new[223]|new[224]	_	_
28-20	4517-4524	cohorts	abstract[220]|abstract[221]|abstract[223]|person[224]	new[220]|new[221]|new[223]|new[224]	_	_
28-21	4525-4528	and	_	_	_	_
28-22	4529-4532	has	_	_	_	_
28-23	4533-4544	potentially	abstract[225]	new[225]	_	_
28-24	4545-4550	large	abstract[225]	new[225]	_	_
28-25	4551-4563	implications	abstract[225]	new[225]	_	_
28-26	4564-4566	on	abstract[225]	new[225]	_	_
28-27	4567-4579	pre-surgical	abstract[225]|abstract[226]	new[225]|giv[226]	coref	31-11[0_226]
28-28	4580-4590	assessment	abstract[225]|abstract[226]	new[225]|giv[226]	_	_
28-29	4591-4594	and	_	_	_	_
28-30	4595-4606	counselling	_	_	_	_
28-31	4607-4609	in	_	_	_	_
28-32	4610-4615	older	person[227]	giv[227]	_	_
28-33	4616-4624	patients	person[227]	giv[227]	_	_
28-34	4625-4629	with	person[227]	giv[227]	_	_
28-35	4630-4633	DCM	person[227]|abstract	giv[227]|giv	coref	31-14[254_0]
28-36	4634-4635	.	_	_	_	_

#Text=However , age-related effects on health perception have been found to influence the SF-36 score , and the contribution from the perception of physical effects often misses a number of important determinants of overall quality of life in older persons .
29-1	4636-4643	However	_	_	_	_
29-2	4644-4645	,	_	_	_	_
29-3	4646-4657	age-related	abstract[229]	giv[229]	coref	29-24[236_229]
29-4	4658-4665	effects	abstract[229]	giv[229]	_	_
29-5	4666-4668	on	abstract[229]	giv[229]	_	_
29-6	4669-4675	health	abstract[229]|abstract|abstract[231]	giv[229]|new|giv[231]	_	_
29-7	4676-4686	perception	abstract[229]|abstract[231]	giv[229]|giv[231]	_	_
29-8	4687-4691	have	_	_	_	_
29-9	4692-4696	been	_	_	_	_
29-10	4697-4702	found	_	_	_	_
29-11	4703-4705	to	_	_	_	_
29-12	4706-4715	influence	_	_	_	_
29-13	4716-4719	the	abstract[233]	new[233]	_	_
29-14	4720-4725	SF-36	abstract|abstract[233]	giv|new[233]	_	_
29-15	4726-4731	score	abstract[233]	new[233]	_	_
29-16	4732-4733	,	_	_	_	_
29-17	4734-4737	and	_	_	_	_
29-18	4738-4741	the	abstract[234]	new[234]	_	_
29-19	4742-4754	contribution	abstract[234]	new[234]	_	_
29-20	4755-4759	from	abstract[234]	new[234]	_	_
29-21	4760-4763	the	abstract[234]|abstract[235]	new[234]|new[235]	_	_
29-22	4764-4774	perception	abstract[234]|abstract[235]	new[234]|new[235]	_	_
29-23	4775-4777	of	abstract[234]|abstract[235]	new[234]|new[235]	_	_
29-24	4778-4786	physical	abstract[234]|abstract[235]|abstract[236]	new[234]|new[235]|giv[236]	_	_
29-25	4787-4794	effects	abstract[234]|abstract[235]|abstract[236]	new[234]|new[235]|giv[236]	_	_
29-26	4795-4800	often	_	_	_	_
29-27	4801-4807	misses	_	_	_	_
29-28	4808-4809	a	abstract[237]	new[237]	coref	30-15[246_237]
29-29	4810-4816	number	abstract[237]	new[237]	_	_
29-30	4817-4819	of	abstract[237]	new[237]	_	_
29-31	4820-4829	important	abstract[237]	new[237]	_	_
29-32	4830-4842	determinants	abstract[237]	new[237]	_	_
29-33	4843-4845	of	abstract[237]	new[237]	_	_
29-34	4846-4853	overall	abstract[237]|abstract[238]	new[237]|new[238]	ana	30-5[0_238]
29-35	4854-4861	quality	abstract[237]|abstract[238]	new[237]|new[238]	_	_
29-36	4862-4864	of	abstract[237]|abstract[238]	new[237]|new[238]	_	_
29-37	4865-4869	life	abstract[237]|abstract[238]|abstract	new[237]|new[238]|giv	coref	30-15
29-38	4870-4872	in	abstract[237]|abstract[238]	new[237]|new[238]	_	_
29-39	4873-4878	older	abstract[237]|abstract[238]|person[240]	new[237]|new[238]|new[240]	_	_
29-40	4879-4886	persons	abstract[237]|abstract[238]|person[240]	new[237]|new[238]|new[240]	_	_
29-41	4887-4888	.	_	_	_	_

#Text=For these reasons , it has been suggested that the focus of quality of life determinants in the elderly should be weighted toward mental components rather than the physical .
30-1	4889-4892	For	_	_	_	_
30-2	4893-4898	these	abstract[241]	new[241]	_	_
30-3	4899-4906	reasons	abstract[241]	new[241]	_	_
30-4	4907-4908	,	_	_	_	_
30-5	4909-4911	it	abstract	giv	coref	30-13
30-6	4912-4915	has	_	_	_	_
30-7	4916-4920	been	_	_	_	_
30-8	4921-4930	suggested	_	_	_	_
30-9	4931-4935	that	_	_	_	_
30-10	4936-4939	the	abstract[243]	new[243]	_	_
30-11	4940-4945	focus	abstract[243]	new[243]	_	_
30-12	4946-4948	of	abstract[243]	new[243]	_	_
30-13	4949-4956	quality	abstract[243]|abstract	new[243]|giv	_	_
30-14	4957-4959	of	abstract[243]	new[243]	_	_
30-15	4960-4964	life	abstract[243]|abstract|abstract[246]	new[243]|giv|giv[246]	_	_
30-16	4965-4977	determinants	abstract[243]|abstract[246]	new[243]|giv[246]	_	_
30-17	4978-4980	in	abstract[243]|abstract[246]	new[243]|giv[246]	_	_
30-18	4981-4984	the	abstract[243]|abstract[246]	new[243]|giv[246]	_	_
30-19	4985-4992	elderly	abstract[243]|abstract[246]	new[243]|giv[246]	_	_
30-20	4993-4999	should	_	_	_	_
30-21	5000-5002	be	_	_	_	_
30-22	5003-5011	weighted	_	_	_	_
30-23	5012-5018	toward	_	_	_	_
30-24	5019-5025	mental	abstract[247]	new[247]	_	_
30-25	5026-5036	components	abstract[247]	new[247]	_	_
30-26	5037-5043	rather	_	_	_	_
30-27	5044-5048	than	_	_	_	_
30-28	5049-5052	the	abstract[248]	new[248]	ana	31-1[0_248]
30-29	5053-5061	physical	abstract[248]	new[248]	_	_
30-30	5062-5063	.	_	_	_	_

#Text=This also raises certain questions about the efficacy of functional assessment measures for DCM in the elderly , but this was beyond the scope of the current study .
31-1	5064-5068	This	abstract	giv	ana	31-20
31-2	5069-5073	also	_	_	_	_
31-3	5074-5080	raises	_	_	_	_
31-4	5081-5088	certain	abstract[250]	new[250]	_	_
31-5	5089-5098	questions	abstract[250]	new[250]	_	_
31-6	5099-5104	about	abstract[250]	new[250]	_	_
31-7	5105-5108	the	abstract[250]|abstract[251]	new[250]|new[251]	_	_
31-8	5109-5117	efficacy	abstract[250]|abstract[251]	new[250]|new[251]	_	_
31-9	5118-5120	of	abstract[250]|abstract[251]	new[250]|new[251]	_	_
31-10	5121-5131	functional	abstract[250]|abstract[251]|abstract[253]	new[250]|new[251]|giv[253]	_	_
31-11	5132-5142	assessment	abstract[250]|abstract[251]|abstract|abstract[253]	new[250]|new[251]|giv|giv[253]	_	_
31-12	5143-5151	measures	abstract[250]|abstract[251]|abstract[253]	new[250]|new[251]|giv[253]	_	_
31-13	5152-5155	for	abstract[250]|abstract[251]|abstract[253]	new[250]|new[251]|giv[253]	_	_
31-14	5156-5159	DCM	abstract[250]|abstract[251]|abstract[253]|abstract[254]	new[250]|new[251]|giv[253]|giv[254]	_	_
31-15	5160-5162	in	abstract[250]|abstract[251]|abstract[253]|abstract[254]	new[250]|new[251]|giv[253]|giv[254]	_	_
31-16	5163-5166	the	abstract[250]|abstract[251]|abstract[253]|abstract[254]	new[250]|new[251]|giv[253]|giv[254]	_	_
31-17	5167-5174	elderly	abstract[250]|abstract[251]|abstract[253]|abstract[254]	new[250]|new[251]|giv[253]|giv[254]	_	_
31-18	5175-5176	,	_	_	_	_
31-19	5177-5180	but	_	_	_	_
31-20	5181-5185	this	abstract	giv	_	_
31-21	5186-5189	was	_	_	_	_
31-22	5190-5196	beyond	_	_	_	_
31-23	5197-5200	the	abstract[256]	new[256]	_	_
31-24	5201-5206	scope	abstract[256]	new[256]	_	_
31-25	5207-5209	of	abstract[256]	new[256]	_	_
31-26	5210-5213	the	abstract[256]|abstract[257]	new[256]|giv[257]	_	_
31-27	5214-5221	current	abstract[256]|abstract[257]	new[256]|giv[257]	_	_
31-28	5222-5227	study	abstract[256]|abstract[257]	new[256]|giv[257]	_	_
31-29	5228-5229	.	_	_	_	_
